# Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data

> **NCT07631806** · — · ACTIVE_NOT_RECRUITING · sponsor: **Guangxi Medical University** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer With PSA Gray Zone

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07631806
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631806, "Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07631806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*